Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02410837 · ClinicalTrials.gov registry record
NAVIGATE: Clinical Evaluation of superDimension™ Navigation System for Electromagnetic Navigation Bronchoscopy™
A clinical trial, sponsored by Medtronic - MITG.
- Completed
- Registry status
- 1,388
- Enrollment target
NCT02410837: Completed study, sponsored by Medtronic - MITG.
NCT02410837 is a clinical trial that has completed, run by Medtronic - MITG. The registered enrollment target is 1,388 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02410837 has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- 1,388 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate outcomes following electromagnetic navigation bronchoscopy™ (ENB™) procedures using the superDimension™ navigation system.
Primary Outcome
The primary endpoint is the incidence of pneumothorax related to the ENB™ index procedure rated as Grade 2 or higher according to the Common Terminology Criteria for Adverse Events (CTCAE) scale. Pneumothorax is a disorder characterized by abnormal presence of air in the pleural cavity resulting in the collapse of the lung. Severity increases as grade increases. Grade 1: Asymptomatic; clinical or diagnostic observations only; intervention not indicated; Grade 2: Symptomatic; intervention indic
Interventions
- PROCEDURE Electromagnetic Navigation Bronchoscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,388 participants |
| Start Date | 2015-04-16 |
| Est. Completion | 2019-11-01 |
What the finished NCT02410837 record still lists
NCT02410837 is an observational study that tracks outcomes without assigning an intervention. Its 1,388 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Electromagnetic Navigation Bronchoscopy is the first listed.
NCT02410837 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02410837 about?
NCT02410837 is a clinical study titled "NAVIGATE: Clinical Evaluation of superDimension™ Navigation System for Electromagnetic Navigation Bronchoscopy™". The purpose of this study is to evaluate outcomes following electromagnetic navigation bronchoscopy™ (ENB™) procedures using the superDimension™ navigation system.
What is the current status of trial NCT02410837?
This trial is currently completed. The enrollment target is 1,388 participants. The study started on 2015-04-16. Estimated completion is 2019-11-01.
What interventions are being tested in trial NCT02410837?
The interventions under investigation include: Electromagnetic Navigation Bronchoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT02410837?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05006131 · 1,395 participants
Pancreatic Cancer Screening for At-risk Individuals
- NCT06651281 · 1,380 participants · Phase 3
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- NCT02205762 · 1,400 participants · Phase 2
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
- NCT02445222 · 1,400 participants · Phase 3
CAR-T Long Term Follow Up (LTFU) Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI